Concept information
...
main group molecular entity
p-block molecular entity
carbon group molecular entity
organic molecular entity
...
ceramide
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
ceramide
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
ceramide
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
ceramide
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
ceramide
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
ceramide
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
neutral glycosphingolipid
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
neutral glycosphingolipid
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
neutral glycosphingolipid
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
neutral glycosphingolipid
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
neutral glycosphingolipid
oligoglycosylceramide
glycohexaosylceramide
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
glycolipid
glycosphingolipid
globoside
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
glycolipid
glycosphingolipid
globoside
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
...
sphingolipid
glycosphingolipid
globoside
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
اصطلاح مرجح
beta-d-gal-(1->3)-[beta-d-glcnac-(1->6)]-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-n-acylsphinganine
نوع
-
http://www.irandoc.ac.ir/onto/irandoc-meta/Concept
مفهوم اعم
بار
- 0
فرمول
- C59H104N3O33R
والد-عملکردی دارد
جرم
- 1383.460
جرم تکایزوتوپی
- 1382.65521
اسمایلٓ
- [C@H]([C@@H](CCCCCCCCCCCCCCC)O)(NC(=O)*)CO[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@@H]([C@H](O[C@@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO[C@H]5[C@@H]([C@H]([C@H](O)[C@H](O5)CO)O)NC(C)=O)O[C@@H]6O[C@@H]([C@H](O)[C@@H]([C@H]6O)O)CO)NC(C)=O)[C@H]([C@H](O3)CO)O)O)[C@@H]([C@H]2O)O)CO)[C@@H]([C@H]1O)O)CO
زیرمجموعه
- 2_STAR
مترادف مرتبط
- beta-D-GlcNAc-(1->6)-Gb5Cer(d18:0)
- beta-D-GlcNAc-(1->6)-SSEA-3(d18:0)
- globoside GlcNAc-GalGb4Cer (d18:0)
در زبان های دیگر
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:140704
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}

